Iniparib is an irreversible PARP1 inhibitor. Studies show that potential therapeutic agent for the treatment of cancer, including triple-negative breast cancer.
Molecular Weight:
292.03
CAS Number:
[160003-66-7]
* VAT and and shipping costs not included. Errors and price changes excepted
